|
1
|
O'Neill AC, Jagannathan JP and Ramaiya NH:
Evolving cancer classification in the era of personalized medicine:
A primer for radiologists. Korean J Radiol. 18:6–17. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lechner MG, Karimi SS, Barry-Holson K,
Angell TE, Murphy KA, Church CH, Ohlfest JR, Hu P and Epstein AL:
Immunogenicity of murine solid tumor models as a defining feature
of in vivo behavior and response to immunotherapy. J Immunother.
36:477–489. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Miller KD, Siegel RL, Lin CC, Mariotto AB,
Kramer JL, Rowland JH, Stein KD, Alteri R and Jemal A: Cancer
treatment and survivorship statistics, 2016. CA Cancer J Clin.
66:271–289. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rolston KVI: Infections in cancer patients
with solid tumors: A review. Infect Dis Ther. 6:69–83. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu H, Dong Y, Gao Y, Du Z, Wang Y, Cheng
P, Chen A and Huang H: The fascinating effects of baicalein on
cancer: A review. Int J Mol Sci. 17:172016. View Article : Google Scholar
|
|
6
|
Lee W, Ku SK and Bae JS: Anti-inflammatory
effects of baicalin, baicalein, and wogonin in vitro and in vivo.
Inflammation. 38:110–125. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang Y, Song L, Cai L, Wei R, Hu H and
Jin W: Effects of baicalein on apoptosis, cell cycle arrest,
migration and invasion of osteosarcoma cells. Food Chem Toxicol.
53:325–333. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen YJ, Wu CS, Shieh JJ, Wu JH, Chen HY,
Chung TW, Chen YK and Lin CC: Baicalein triggers
mitochondria-mediated apoptosis and enhances the antileukemic
effect of vincristine in childhood acute lymphoblastic leukemia
CCRF-CEM cells. Evid Based Complement Alternat Med.
2013:1247472013.PubMed/NCBI
|
|
9
|
Wang Z, Jiang C, Chen W, Zhang G, Luo D,
Cao Y, Wu J, Ding Y and Liu B: Baicalein induces apoptosis and
autophagy via endoplasmic reticulum stress in hepatocellular
carcinoma cells. Biomed Res Int. 2014:7325162014.PubMed/NCBI
|
|
10
|
Wang YF, Li T, Tang ZH, Chang LL, Zhu H,
Chen XP, Wang YT and Lu JJ: Baicalein triggers autophagy and
inhibits the protein kinase B/mammalian target of rapamycin pathway
in hepatocellular carcinoma HepG2 cells. Phytother Res. 29:674–679.
2015. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen K, Zhang S, Ji Y, Li J, An P, Ren H,
Liang R, Yang J and Li Z: Baicalein inhibits the invasion and
metastatic capabilities of hepatocellular carcinoma cells via
down-regulation of the ERK pathway. PLoS One. 8:e729272013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim C, Yang H, Fukushima Y, Saw PE, Lee J,
Park JS, Park I, Jung J, Kataoka H, Lee D, et al: Vascular RhoJ is
an effective and selective target for tumor angiogenesis and
vascular disruption. Cancer Cell. 25:102–117. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sundar SS and Ganesan TS: Role of
lymphangiogenesis in cancer. J Clin Oncol. 25:4298–4307. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gomes FG, Nedel F, Alves AM, Nör JE and
Tarquinio SB: Tumor angiogenesis and lymphangiogenesis:
Tumor/endothelial crosstalk and cellular/microenvironmental
signaling mechanisms. Life Sci. 92:101–107. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Foubert P and Varner JA: Integrins in
tumor angiogenesis and lymphangiogenesis. Methods Mol Biol.
757:471–486. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dong LH, Wen JK, Miao SB, Jia Z, Hu HJ,
Sun RH, Wu Y and Han M: Baicalin inhibits PDGF-BB-stimulated
vascular smooth muscle cell proliferation through suppressing PDGFR
beta-ERK signaling and increase in p27 accumulation and prevents
injury-induced neointimal hyperplasia. Cell Res. 21:1276. 2011.
View Article : Google Scholar :
|
|
18
|
Ling Y, Chen Y, Chen P, Hui H, Song X, Lu
Z, Li C, Lu N and Guo Q: Baicalein potently suppresses angiogenesis
induced by vascular endothelial growth factor through the p53/Rb
signaling pathway leading to G1/S cell cycle arrest. Exp Biol Med.
236:851–858. 2011. View Article : Google Scholar
|
|
19
|
Huang Y, Miao Z, Hu Y, Yuan Y, Zhou Y, Wei
L, Zhao K, Guo Q and Lu N: Baicalein reduces angiogenesis in the
inflammatory microenvironment via inhibiting the expression of
AP-1. Oncotarget. 8:883–899. 2017.PubMed/NCBI
|
|
20
|
Cathcart MC, Useckaite Z, Drakeford C,
Semik V, Lysaght J, Gately K, O'Byrne KJ and Pidgeon GP:
Anti-cancer effects of baicalein in non-small cell lung cancer
in-vitro and in-vivo. BMC Cancer. 16:7072016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Trédan O, Galmarini CM, Patel K and
Tannock IF: Drug resistance and the solid tumor microenvironment. J
Natl Cancer Inst. 99:1441–1454. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yamashita S, Baba K, Makio A, Kumazoe M,
Huang Y, Lin IC, Bae J, Murata M, Yamada S and Tachibana H:
γ-Tocotrienol upregulates aryl hydrocarbon receptor expression and
enhances the anticancer effect of baicalein. Biochem Biophys Res
Commun. 473:801–807. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu TY, Gong W, Tan ZJ, Lu W, Wu XS, Weng
H, Ding Q, Shu YJ, Bao RF, Cao Y, et al: Baicalein inhibits
progression of gallbladder cancer cells by downregulating ZFX. PLoS
One. 10:e01148512015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dong LH, Wen JK, Miao SB, Jia Z, Hu HJ,
Sun RH, Wu Y and Han M: Baicalin inhibits PDGF-BB-stimulated
vascular smooth muscle cell proliferation through suppressing
PDGFRβ-ERK signaling and increase in p27 accumulation and prevents
injury-induced neointimal hyperplasia. Cell Res. 20:1252–1262.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cébe-Suarez S, Zehnder-Fjällman A and
Ballmer-Hofer K: The role of VEGF receptors in angiogenesis;
complex partnerships. Cell Mol Life Sci. 63:601–615. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Appelmann I, Liersch R, Kessler T, Mesters
RM and Berdel WE: Angiogenesis inhibition in cancer therapy:
platelet-derived growth factor (PDGF) and vascular endothelial
growth factor (VEGF) and their receptors: biological functions and
role in malignancy. Recent Results Cancer Res. 180:51–81. 2010.
View Article : Google Scholar : PubMed/NCBI
|
